With SottoPelle hormone therapy, our patients can achieve a healthy and balanced life. Knowing the ideal amount of hormones necessary for each body’s health makes all the difference in every aspect.

For hormone replacement when hormone deficiency is proven: testosterone in men, testosterone and estradiol in post-menopausal women. There is also a third drug, synthetic progesterone (progestin), used to treat symptoms of a syndrome called estrogen dominance, which causes severe menstrual cramps, severe PMS, heavy menstrual bleeding, uterine fibroids, endometriosis, adenomyosis, breast cysts, and other symptoms.

Under the skin, with local anesthesia in a laboratory environment, in the upper gluteal area (bikini mark) in women and in the flanks (love handles) in men.

Our hormone implants last an average of 4 to 6 months. This is the minimum period for the treatment to be carried out. However, each patient is unique, so the dialogue with the doctor is essential to understand the necessary treatment time in your case.

There is no maximum age, as our founder Dr. Gino Tutera used to say: “you are never too old to undergo hormone replacement therapy.”

SottoPelle Brazil has a dosage calculation platform called Hormocalc. When your doctor enters your biometric data, symptoms and signs, radiological and laboratory reports, physical activity level, etc., the platform calculates the need for hormone replacement, if it exists, and then the type of hormone is correctly indicated for you in the correct and individualized dosage. This avoids overdosing (and its side effects) and underdosing (few clinical effects), making hormone replacement therapy much safer and more effective.

No, because there are two large groups of hormones produced pharmacologically: isomolecular, whose chemical composition is identical to what the human body produces, and synthetic steroids, whose chemical composition is different from what the human body produces. Our testosterone and estradiol implants are absolutely made from pure isomolecular hormones.

Recent studies have shown that isomolecular hormones, in addition to greatly improving the quality of life in postmenopausal women and men in andropause, do not increase the risk of developing cancer. Some studies have shown that hormone replacement therapy with isomolecular hormones in physiological doses, such as testosterone for men, can reduce the risk of prostate cancer in men and breast cancer in women, contrary to what was previously preached by old studies on hormone replacement therapy with synthetic hormones.

A precise clinical, laboratory, and radiological medical evaluation performed by a certified professional in our therapy will evaluate your case individually, and after this extensive and thorough study, you will have your correct and personalized diagnosis.

Around the world, only doctors who hold certification in SottoPelle therapy can access our technology and treat our patients. To find out where there is a professional closest to you, click on the “Find your doctor” menu on our site.

Yes. SottoPelle is the only global company in hormone replacement therapy in the form of absorbable subcutaneous implants, created in the United States of America in 1991. Since then, more than 250,000 patients have benefited from this safe, effective technique with great results over 30 years of history. In Brazil, SottoPelle has existed since 2019, and our country is the first in Latin America to receive this differentiated medical and health technology.